These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 8639004)

  • 1. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):417-8. PubMed ID: 12419166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
    Christensen KL
    Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
    [No Abstract]   [Full Text] [Related]  

  • 3. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
    MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low-dose perspective on the calcium antagonist controversy.
    Bloomfield RL; Miller HS; Pedley CF; Colflesh MJ; Novikov S
    Arch Intern Med; 1996 May; 156(10):1115-6. PubMed ID: 8639004
    [No Abstract]   [Full Text] [Related]  

  • 7. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of calcium-channel blockers in pregnancy.
    Lewis R; Sibai BM
    New Horiz; 1996 Feb; 4(1):115-22. PubMed ID: 8689266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of calcium antagonists in the treatment of arterial hypertension].
    Chazova IE
    Ter Arkh; 2001; 73(8):80-3. PubMed ID: 11599278
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication].
    Birkenhäger WH; de Leeuw PW; Staessen JA; Wang JG; Forette F; Seux ML
    Ned Tijdschr Geneeskd; 2000 Jul; 144(31):1469-74. PubMed ID: 10941432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists in hypertension: first-line antihypertensive agents?
    Ambrosioni E
    Blood Press Suppl; 1996; 5():5-6. PubMed ID: 8973785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mibefradil--a T-type calcium channel blocker].
    Roguin A; Edoute Y
    Harefuah; 1999 Jan; 136(2):167-9. PubMed ID: 10914190
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.